Life sciences in Cambridge is built on intellectual entrepreneurialism and the collaboration between our research community – a nexus of ground-breaking research institutions and world leading hospitals, all with strong links to the private sector.
The Cambridge life sciences cluster is globally unique in its geographic concentration of world-class capabilities—a truly extraordinary entrepreneurial community where research, industry, and health join forces to tackle the biggest healthcare challenges facing the world today
Laurel Powers-Freeling
Chair, Cambridge University Health Partners
The Cambridge life sciences cluster is globally unique in its geographic concentration of world-class capabilities—a truly extraordinary entrepreneurial community where research, industry, and health join forces to tackle the biggest healthcare challenges facing the world today
Laurel Powers-Freeling
Chair, Cambridge University Health Partners
Home to over 20 Nobel Prize winners in life sciences since 2000, the University of Cambridge underpins the knowledge engine for the surrounding cluster. Further, the region has benefited from significant investment in critical research base initiatives such as the MRC Laboratory of Molecular Biology, Wellcome Sanger Institute, , CRUK Cambridge Institute and EMBL European Bioinformatics Institute.
mogrify.co.uk
Transforming Cell Therapy & Regenerative Medicine
Mogrify® represents a unique opportunity to transform the development of ex vivo cell therapies, as well as pioneer a new class of in vivo reprogramming therapies for diseases with high unmet clinical need.
As a global hub for Life Sciences, Healthcare and Technology, Cambridge provides a launchpad for scientists, entrepreneurs and students alike, nurturing disruptive innovation, such as the MOGRIFY® platform, and powering the commercialization of such technologies to address therapeutic, industrial and societal needs.
Darrin M. Disley OBE, CEO
tuspark.co.uk
TusPark is a leading global ecosystem in comprehensive innovation service
As one of the largest owners and operator of science parks and incubation facilities in the world, TusPark aims to create an environment that fuels creative and lateral thinking.
As one of the largest owners and operator of science parks and incubation facilities in the world, TusPark aims to create an environment that fuels creative and lateral thinking.
Kevin Lin, President
The concentration of expertise in Cambridge has resulted in the leadership of national initiatives, including the NIHR BioResource and Health Data Research UK. These have allowed the UK to take a world-leading role in advanced therapies, data science and genomics. Three highly-respected NHS Trusts work with industry to translate innovation into patient benefit, hosting the largest National Institute for Health Research (NIHR) Biomedical Research Centre in the UK.
Productive interactions between industry scientists, clinicians and academics are facilitated through state-of-the-art research infrastructure and multiple science and technology parks. As such, public sector investment in the East of England currently leverages over four times the amount of investment from business R&D, representing the highest ratio in the UK.
In Cambridge, opportunity is everywhere. It is a place where scientists, businesses, clinicians and entrepreneurs converge to co-create the transformative therapies of the future.
Kathryn Chapman,
Director of Science and Entrepreneurship,
Babraham Research Campus
Notable recent highlights
Cambridge Immunity Experimental Medicine Unit
The proposed Immunity Experimental Medicine Unit (iEMU) will enable human experimental medicine studies into COVID-19, accelerating the delivery of vaccines, antivirals and other therapies to the clinic. The proposal is supported by GlaxoSmithKline and AstraZeneca and will play a key part of supporting the pharmaceutical and biotechnology industries.
PerkinElmer acquires Horizon Discovery
Sanofi completes Kymab acquisition
Case study
bit.bio is developing a scalable technology platform capable of producing consistent batches of every human cell.
Coding cells for healthOther needs for this sector
Cambridge& is here to help
A warm welcome to Cambridge&. We look forward to working with you in accessing the Greater Cambridge ecosystem, to support your plans for locating, partnering and/or scaling here. Cambridge is a safe place to do risky things – for the good of the world.
If you would like to discuss anything please send me a message through the form or give me a call on +44 (0) 7585 290733
Best wishes
Duncan
Duncan McCunn
CEO
Cambridge&